Abstract
We report an unusual case of spontaneous intramuscular hematoma associated with antiproteinase 3 antibody in a patient with metastatic squamous cell carcinoma receiving nivolumab and the medical literature is reviewed.
Keywords:
PD-1/PD-L1 inhibitor; nivolumab; spontaneous hematoma; squamous cell carcinoma of lung.
MeSH terms
-
Antineoplastic Agents, Immunological / adverse effects*
-
Carcinoma, Squamous Cell / drug therapy*
-
Carcinoma, Squamous Cell / immunology
-
Carcinoma, Squamous Cell / secondary
-
Hematoma / etiology*
-
Humans
-
Male
-
Middle Aged
-
Myeloblastin / immunology*
-
Nivolumab / adverse effects*
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Thigh
-
Tonsillar Neoplasms / pathology*
Substances
-
Antineoplastic Agents, Immunological
-
Programmed Cell Death 1 Receptor
-
Nivolumab
-
Myeloblastin